Amazon Great Indian Festival 2020 - Electronics
Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Amazon Great Indian Festival 2020 - Electronics
Research

| More

Zydus Cadila receives US FDA approval - Angel Broking

Posted On: 2020-09-24 23:55:27


Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd

Zydus Cadila has received final approval from the USFDA to market Dimethyl Fumarate DelayedRelease Capsules, (US RLD: Tecfidera®) in the strengths of 120 mg and 240 mg. In its approval, the USFDA noted that Zydus was one of the first ANDA applicants to submit a substantially complete ANDA and is therefore eligible for 180 days of generic drug exclusivity along with other first ANDA applicants. Dimethyl Fumarate Delayed-Release Capsules are indicated for the treatment of patients with relapsing forms of multiple sclerosis and will be manufactured at the group's manufacturing facility at the SEZ, Matoda. Company now has 303 approvals and has so far filed over 390 ANDAs. This is a positive development for Zydus Cadila.

Shares of CADILA HEALTHCARE LTD. was last trading in BSE at Rs.376.05 as compared to the previous close of Rs. 383.9. The total number of shares traded during the day was 110488 in over 2727 trades.

The stock hit an intraday high of Rs. 383.8 and intraday low of 373.95. The net turnover during the day was Rs. 41874067.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com

Amazon Great Indian Festival 2020 - Mobiles


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Kajaria Ceramics - Q2FY21 First Cut - ICICI Securities

Quant Pick - Larsen & Toubro - ICICI Securities

Hindustan Unilever - Q2FY21 First Cut - ICICI Securities

Hindustan Zinc - Q2FY21 First Cut - ICICI Securities

Dhanuka Agritech - Buy back - Angel Broking

Equitas SFB IPO - Day 1 Subscription - Angel Broking

Dr. Reddy's lab relaunch of OTC product - Angel Broking

Hindustan Unilever Ltd - Q2FY21 Results - Angel Broking

Hindustan Unilever Ltd - Q2FY21 Results - YES Securities

Maintain BUY on ACC - Strong cost controls cushion earnings - HDFC Securities

Equitas Small Finance Bank (ESFB) - Subscribe - YES Securities

Granules India - Q2FY2021 results - Angel Broking

Sunteck Realty - Acquisition of 50 acres - Angel Broking

Maintain BUY on Oberoi Realty - Sharp recovery - HDFC Securities

L&T bidding for rail corridor - Angel Broking

Maintain REDUCE on L&T Technology Services - Recovery priced in - HDFC Securities

India IT Services - Thematic - Rising 5G Adoption to Industrialize Digital Services & Connectivity - Reliance Securities

L&T Technology Services - Q2FY21 Result - Angel Broking

L&T Technology Services - 'Multiple' headwinds - ICICI Securities

HDFC Life Insurance Company - Recovery well on track post Covid-19 dip - ICICI Securities

ACC - Strong execution - third time in a row - ICICI Securities

Tata Communications - Keeping faith on sales funnel for revenue growth - ICICI Securities

Hatsun Agro Products - Healthy revenues; strong margins - ICICI Securities

Amber Enterprises Ltd - Business Update Call - YES Securities

Key Takeaways from Q2FY21 earnings call of Shoppers Stop - YES Securities

CSB Bank Q2 FY21 - Not Rated - YES Securities

Britannia Industries 2QFY21 results - YES Securities

HDFC Life Insurance - Q2FY21 Results - YES Securities

ACC Ltd - Q3CY20 Results - YES Securities

IPO Review - Equitas Small Finance Bank - ICICI Securities

Rallis India - Q2FY21 First Cut - ICICI Securities

ACC Ltd - Q3CY20 First Cut - ICICI Securities

Equitas Small Finance Bank Limited - Strongly developing from a microfinance to small bank... - Geojit

Britannia Industries - Q2FY21 Results - Angel Broking

Rallis India - Q2FY21 Results - Angel Broking

Equitas Small Finance Bank - IPO Note - Angel Broking

ACC Ltd - Q3CY20 Result - Angel Broking

Oberoi Realty - Q2FY21 Result - Angel Broking

Tata Communications - Q2FY21 Result - Angel Broking

India trade deficit for September 2020 - Angel Broking

Route Mobile - 19th October 2020 - Angel Broking

Thomas Cook India and SOTC partner with Accor - Launch Holiday Safe

Alembic Pharmaceuticals - USFDA approval for Amantadine Hydrochloride Tablets - Angel Broking

Maintain REDUCE on Avenue Supermarts - Recovery tracking well - HDFC Securities

HDFC Bank - Q2FY21 Result - Angel Broking

HDFC Bank - Q2FY21RU report - YES SECURITIES

Bajaj Consumer Care - Faster-than-expected recovery - ICICI Securities

HCL Technologies - Strong quarter; modest near-term outlook - ICICI Securities

Shoppers Stop - Strengthening balance sheet & inducting new MD - ICICI Securities

Alkem Laboratories - Outlook remains strong - ICICI Securities







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019